This inventor holds 3 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Regeneron Pharmaceuticals, Inc., Sanofi Biotechnology, Sanofi. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,482 
2 out of 40 
1 out of 1,547 
Years Active: 2019-2024
Title: The Innovative Mind of Uwe Schwahn
Introduction
Uwe Schwahn, a notable inventor based in Frankfurt am Main, Germany, has made significant contributions to the fields of biotechnology and pharmaceuticals. With a total of three patents to his name, his work primarily focuses on developing novel solutions for medical challenges, particularly in relation to cardiovascular health and targeted therapies.
Latest Patents
Uwe Schwahn's latest patents include two groundbreaking inventions that showcase his innovative spirit. The first patent involves FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof with GLP-1R agonistic peptides. This patent describes proteins with improved physico-chemical properties and pharmaceutical compositions that can be used in medical treatments. The second patent outlines methods for inhibiting atherosclerosis through the administration of an anti-PCSK9 antibody, providing a promising approach for targeting atherosclerotic plaque formation.
Career Highlights
Throughout his career, Uwe Schwahn has been associated with renowned companies such as Sanofi Biotechnology and Regeneron Pharmaceuticals, Inc. His work in these organizations has facilitated advancements in research and development within the biotechnology sector, showcasing his role as a key player in bringing innovative treatments to market.
Collaborations
Uwe has collaborated with notable professionals in his field, including William J. Sasiela and Viktoria Gusarova. These partnerships have further enriched his research efforts and contributed to the success of his patent applications.
Conclusion
Uwe Schwahn exemplifies the spirit of innovation, combining scientific expertise with a commitment to improving health outcomes. His patents not only reflect his creative ingenuity but also contribute to the ongoing evolution of medical treatments in the biotechnology industry. As he continues to push the boundaries of research, Uwe remains a prominent figure to watch in the realm of inventions and innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile